Recent Finacing
Recent Raise
Primrose Bio develops and licenses end-to-end nucleic acid and protein manufacturing technologies—Prima RNApols for mRNA, Pfenex Expression production system, and PeliCRM197 vaccine carrier protein.
Focus Areas
Recent Investors
Funding round
Investor
See the team members at Primrose Bio.
